Visit this section

Healthcare professionals


Welcome to

An essential resource for healthcare
professionals treating people with

Find out what’s NEW

Recordati Webinar Program 2022

As a service to the psychiatric profession, Recordati is pleased to announce its 6th series of webinars for mental health professionals.

Psychiatric Forum
Nordic Webinar

Now you can watch the Nordic Webinar with Prof Stephen M. Stahl and Dr Johan Sahlsten Schölin until 30th of September 2022.

Keep up to date on schizophrenia and Reagila with our newsletter.

Subscribe here

Mastering the Diagnosis of Schizophrenia

Since no blood test or brain scan exists for schizophrenia, a great deal of attention must be paid to the constellation of symptoms that best define schizophrenia to ensure accurate diagnosis.

How do you diagnose?


  1. American Psychiatric Association. DSM-5 Diagnostic Classification in Diagnostic and Statistical Manual of Mental Disorders (2013). doi:10.1176/ appi.books.9780890425596.x00 diagnosticclassification
  2. WHO. International statistical classification of diseases and related health problems – 10th revision. World Heal. Organ. (2011).
ICD and DSM Criteria for schizophrenia - comparison
ICD and DSM Criteria for schizophrenia - comparison

What is the Connection Between Inflammation and Schizophrenia?

Maternal Immune ActivationMaternal Immune Activation

Over the last few decades there has been increasing interest in early intervention and prevention of schizophrenia, a topic recently reviewed by Hashimoto and published in the Current Psychiatry Reports journal.1


  1. Hashimoto. Current Psychiatry Reports. 2019;21:75

Interview with Prof. LLORCA

Latest trends in schizophrenia treatment

Prof. Llorca talks about functioning and innovative approaches to schizophrenia treatment.

Watch the full interview here

    Treating Schizophrenia

    The goal of schizophrenia treatment is to reduce the frequency and severity of psychotic episodes, as well as to improve the functional capacity and quality of life of individuals with schizophrenia, ultimately resulting in patient recovery and reintegration.

    Treatment Goals


    1. Haller, C. S., Padmanabhan, J. L., Lizano, P., Torous, J. & Keshavan, M. Recent advances in understanding schizophrenia. F1000Prime Rep. 6, 1–11 (2014).
    The goals of treating schizophrenia
    The goals of treating schizophrenia

    The Challenge of Negative Symptoms in Schizophrenia

    Negative symptoms can be difficult to recognize as part of schizophrenia, they are rarely the reason patients seek help, and treatment remains a challenge for patients with these complicated and heterogeneous symptoms 1,2.

    Negative Symptoms Across the Disease


    1. National Institutes of Mental Health (NIMH). Schizophrenia. (2017). Available at:
    2. Fischer, B. A. & Buchanan, R. W. Schizophrenia: Clinical Manifestations, Course, Assessment and Diagnosis. UpToDate (2017). Available at: www.up-to-date/schizophrenia.
    3. Lieberman, J. A. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol. Psychiatry 50, 884–897 (2001).

    Login to Unlock


    Cariprazine has high affinity for dopamine D3 and D2 receptors as well as serotonin 5 HT2B and 5 HT1A receptors, moderate affinity to 5 HT2A, histamine H1, and Find out more about its mechanism of action

    Login to Unlock


    The clinical efficacy profile of typical antipsychotic agents appears to depend on high affinity for and full antagonist activity at dopamine D2 receptors. Due The clinical efficacy profile of typical antipsychotic agents appears to depend on high affinity for and full antagonist activity at dopamine D2 receptors. Due

    Showing 0 result(s).
    Please log in to see 0 more result(s).